EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH

1 entry found
1
Journal article icon
Journal article

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial

  • Mease, P, Coates, L, Helliwell, P, et al.
  • 2018-10-22
File available icon
Peer reviewed icon
Link to publisher copy available icon
FILTER RESULTS

TO TOP